|Denaro||0,00 x 0|
|Lettera||0,00 x 0|
|Min-Max giorno||96,56 - 97,83|
|Intervallo di 52 settimane||96,56 - 97,83|
|Beta (5 anni mensile)||0,72|
|Rapporto PE (ttm)||0,16|
|Prossima data utili||02 nov 2022|
|Rendimento e dividendo (forward)||N/D (N/D)|
|Data ex dividendo||N/D|
|Stima target 1A||N/D|
Koios is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement in over 600 CVS locations. CVS is the largest retail pharmacy chain in the United States and one of the largest corporations in the world.DENVER and VANCOUVER, British Columbia, May 09, 2022 (GLOBE NEWSWIRE) -- Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the "Company" or "Koios") is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement and ar
With CVS filing trademark applications, the COVID-19 pandemic could give the healthcare sector a greater incentive to explore NFTs and the Metaverse.
CVS Health reported earnings and revenue that exceeded analysts’ estimates due to higher demand for COVID-19 tests and vaccinations.